CHESS Health Revenue and Competitors

East Rochester, NY USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • CHESS Health's estimated annual revenue is currently $15.1M per year.(i)
  • CHESS Health's estimated revenue per employee is $224,866

Employee Data

  • CHESS Health has 67 Employees.(i)
  • CHESS Health grew their employee count by 24% last year.

CHESS Health's People

NameTitleEmail/Phone
1
CFOReveal Email/Phone
2
VP MarketingReveal Email/Phone
3
VP, SalesReveal Email/Phone
4
Director, OnboardingReveal Email/Phone
5
Development DirectorReveal Email/Phone
6
Senior DirectorReveal Email/Phone
7
Regional DirectorReveal Email/Phone
8
Regional DirectorReveal Email/Phone
9
Director, Customer SuccessReveal Email/Phone
10
Full Stack Development ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.9M23-8%N/AN/A
#2
$13.4M4914%N/AN/A
#3
$25.4M787%N/AN/A
#4
$78.4M26416%N/AN/A
#5
$9.3M330%N/AN/A
#6
$51.1M14811%N/AN/A
#7
$65M1700%N/AN/A
#8
$44.8M1519%N/AN/A
#9
$6.7M31-11%N/AN/A
#10
$9.5M379%N/AN/A
Add Company

What Is CHESS Health?

The First Evidence-Based Platform Automating the Addiction Management Life Cycle Founded in 2014 by nationally recognized substance abuse researcher Dr. Dave Gustafson, CHESS developed A-CHESS (Addiction Comprehensive Health Enhancement Support System), the leading evidence-based relapse prevention technology. A-CHESS provides support for SUD in a variety of environments: • PCPs and Clinics • Emergency Departments • Care Coordinators • Rehab Facilities • Detox Centers • MAT Providers Solutions include: • eIntervention-SUD Referral Management with Patient Engagement • eTherapy-Mobile Delivery of Cognitive Behavioral Therapy • eRecovery-Relapse Prevention and Data Collection CHESS health's evidence-based platform and mobile applications improve recovery by reducing the frequency and severity of relapse. • Connections-Patients • Program Dashboard and Companion-Care Teams • Enterprise Analytics and Benchmarking-Providers and Payers Nationally recognized and validated by the Substance Abuse and Mental Health Services Administration’s National Registry of Evidence-based Programs and Practices (NREPP), the Journal of Substance Abuse and the Surgeon General and the Journal of Substance Abuse as a proven relapse predictor. Clinically Validated Results • 31% fewer patients relapsed (surveyed at 4, 8, and 12 months) • 50% reduction in severity of relapse • 71% reduction in re-hospitalizations • 20% more likely to complete treatment

keywords:N/A

N/A

Total Funding

67

Number of Employees

$15.1M

Revenue (est)

24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$23.1M8917%N/A
#2
$36.8M9514%N/A
#3
$31.4M125N/AN/A
#4
$68.6M1587%N/A